RNS Number : 8364P
Anpario PLC
24 May 2024
 

Anpario plc

("Anpario" or the "Company")

 

Posting of Annual Report and Notice of AGM

 

 

Anpario plc (AIM:ANP), the international producer and distributor of natural animal feed additives for animal health, nutrition and biosecurity, announces that it has published its 2023 Annual Report and Notice of Annual General Meeting ("AGM"), which have today been sent to shareholders who have elected to receive them and which are also available to view on the Company's website at www.anpario.com/investor/.

 

The Board plans to hold the AGM at 11.00 am on Tuesday 25 June 2024 at the offices of DLA Piper UK LLP at 160 Aldersgate Street, EC1A 4HT, London, United Kingdom.

 

The Notice of AGM Notice together with a Form of Proxy are available at www.anpario.com/investor/shareholder-notices/.

 

Further information regarding the arrangements for the AGM and what shareholders should do in order to vote at the AGM are contained in the Notice of AGM.

 

 

 

Enquiries

 

Anpario plc

 

Richard Edwards, Chief Executive Officer

+44(0)7776 417 129

Karen Prior, Corporate Responsibility Director & Company Secretary

+44(0)1909 537 380

Marc Wilson, Group Finance Director

+44(0)1909 537 380

 

 

Shore Capital

 

(Nominated Adviser and Broker)

+44 (0) 20 7408 4090

Stephane Auton

Corporate Advisory

David Coaten

 

Tom Knibbs

 

Henry Willcocks

Corporate Broking

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOASESSALELSEEI